Ana Raposo, country director for Gulf Countries at Janssen discusses her role, the main similarities and differences between the various markets…

The UAE pharma market is projected to grow over 80 percent by 2027, in part due to a growing demand for the treatment of lifestyle diseases and…

The UAE ranks among the world's fastest for new drug approvals, ranking first for two cancer drugs and second for many others, such as blockbuster…

The UAE ranks as a world leader in rapid drug approvals with its fast-track registration system that accelerates the process and eliminates long…

Dubai's government has announced its ambition to go completely paper-free by the end of the year 2021. Its health authority has recently upgraded to a…

Dr Omar Hallak, head of the cardiovascular department at King’s College Hospital Dubai (KCHD) and president of the Gulf chapter of the International…

The UAE's rapid economic growth over the last half-century has been accompanied by a surge in lifestyle diseases such as diabetes and obesity. Both…

The mission of the Swiss Business Council (SBC) is to provide a forum for Swiss executives and those with Swiss business interested to identify,…

LIFEPharma, a subsidiary of UAE-based VPS Healthcare, has signed a Dh 200 million (USD 55 million) deal with Canada’s Apotex to produce 120 million…

PharmaBoardroom highlights three pharma executives whose experience in the Middle East has served to propel them into global leadership positions.…

The top 10 pharma companies in the UAE ranked by 2018 sales according to IQVIA data. Swiss giant Novartis leads the way with USD 196 million in sales,…

We look at three of the most important regulatory trends in UAE healthcare and the impact they stand to have on pharma multinationals, local firms,…